VeriMomVeriMom
HIGH RISK

¿Debo evitar lithium carbonate durante el embarazo? | VeriMom

ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).

ECHA regulatory hazard statements

  • H360
  • H362

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

¿Es lithium carbonate seguro durante el embarazo?
ECHA’s Risk Assessment Committee adopted an opinion classifying lithium carbonate (CAS 554-13-2) as Reproductive Toxicity Category 1A (H360; effect on fertility/foetus) with effects via lactation (H362), which is harmonised-level evidence of reproductive/developmental hazard; clinical and animal literature also document placental transfer and neonatal/fetal effects for systemic (medicinal) lithium exposure. For topical cosmetic use systemic exposure is expected to be negligible (see ECHA registration dossier dermal absorption statement). (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed reviews/studies).
¿Es lithium carbonate seguro durante la lactancia?
ECHA’s adopted opinion includes H362 (dangerous for or via breast‑feeding), and clinical data on medicinal lithium show lithium is excreted in human milk and can produce neonatal toxicity—supporting a high hazard (h=3) and demonstrated mechanism (m=2). For topical cosmetic applications, dermal absorption is considered very poor so direct exposure via cosmetic use is expected to be negligible, though systemic exposure from medicinal use is well documented. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; product/labeling and clinical literature on lithium in breast milk).
¿Es lithium carbonate seguro para la piel del bebé?
Hazard and mechanism are driven by harmonised CLH (Repr.1A H360FD) and clinical/animal evidence of placental transfer and milk excretion—these apply to infants (h=3, m=2). Exposure (e) for topical cosmetic use is judged low/negligible in adults (ECHA: dermal absorption very poor), but infant skin has higher uptake potential so exposure is increased by +1 to e=1 as a precaution for 0–3‑year skin when the ingredient is present in topical products. There is no evidence that cosmetic-grade topical use produces systemic infant exposure, but the harmonised classification leads to conservative scoring for infant contexts. (Sources: ECHA RAC CLH opinion; ECHA registration dossier; PubMed clinical/animal studies).
¿Cómo puntúa VeriMom a lithium carbonate?
VeriMom puntúa lithium carbonate en 27/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
¿Cuáles son las alternativas seguras a lithium carbonate en el embarazo?
Consulta nuestra lista de alternativas seguras a lithium carbonate según función similar y clasificación sin riesgos conocidos.

Comprueba cualquier etiqueta en 2 segundos

Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.

Aviso Médico

Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.

Obtén la experiencia completa en la app VeriMom